Brief: Argenica Therapeutics Appoints CEO Liz Dallimore Managing Director
04/04/2022 07:41
April 4 (Reuters) - Argenica Therapeutics Ltd AGN.AX :
* ARGENICA APPOINTS CEO DR LIZ DALLIMORE MANAGING DIRECTOR
Source text for Eikon: ID:nASXJCP1d
Further company coverage: AGN.AX
Recent news on Argenica Therapeutics
See all newsBrief: Argenica Therapeutics Says IND Application Advanced With Successful Completion Of Assay
Brief: Argenica Therapeutics Says Dianne Angus To Step Down As Non-Executive Chair
Australia's Argenica Therapeutics jumps on meeting FDA condition
Brief: Argenica Therapeutics Seeks Trading Halt
Brief: Argenica Therapeutics Gets Non-Dilutive Funding Up To A Total Of A$1.5M